Search

Scholarly Works (1 results)

Article
Peer Reviewed

Maintenance of serum potassium with sodium zirconium cyclosilicate (ZS-9) in heart failure patients: Results from a phase 3 randomized, double-blind, placebo-controlled trial

Deedwania, Prakash;
Anker, SD;
Kosiborod, M;
Zannad, F;
Piña, IL;
Mccullough, PA;
Filippatos, G;
van, P;
Ponikowski, P;
Rasmussen, HS;
Lavin, PT

UC San Francisco Previously Published Works (2015)

© 2015 European Society of Cardiology. Aims: Hyperkalaemia in heart failure patients limits use of cardioprotective renin-angiotensin-aldosterone system inhibitors (RAASi). Sodium zirconium cyclosilicate (ZS-9) is a selective potassium ion trap, whose mech